Model Number 106524US |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Encephalopathy (1833); Headache (1880); Sepsis (2067); Lethargy (2560); Convulsion/Seizure (4406); Hemorrhagic Stroke (4417)
|
Event Date 02/07/2022 |
Event Type
Death
|
Event Description
|
It was reported that the patient had multiple comorbid conditions including severe congestive heart failure and cardiogenic shock with history of left ventricular assist device implanted in 2021.The patient presented with lethargy, generalized weakness, headache, cough, and confusion to the emergency room.The patient was having seizure activity, twitching on the left side of the face, left arm was jerking, body was stiff, and had rapid eye movements.A computed tomography was performed and showed a 5 by 3 centimeter right hemorrhagic stroke.The patient had an acute large right parietal hemorrhagic stroke, acute metabolic encephalopathy, warfarin coagulopathy, severe sepsis, possible bilateral pneumonia.Doxycycline, warfarin, and complete comfort measures with no stroke order set, only ordered vitals, dilaudid drip, and other comfort medications.The vad was turned off and the patient passed away.
|
|
Manufacturer Narrative
|
Manufacturer's investigation conclusion: a specific cause for the reported events (stroke, sepsis, infection) and subsequent patient outcome as well as a direct correlation to heartmate 3 left ventricular assist system (lvas), serial number (b)(4), could not be conclusively determined through this evaluation.The device was not explanted, and product was not returned for evaluation.The relevant sections of the device history records for (b)(4) were reviewed and showed no deviations from manufacturing or quality assurance specification.The heartmate 3 left ventricular assist system (lvas) instructions for use (ifu) rev.C is currently available.¿introduction¿, lists stroke, bleeding, sepsis, infection, and death as adverse events that may be associated with the use of heartmate 3 lvas.¿patient care and management¿, provides information regarding anticoagulation, including recommended international normalized ratio (inr) values.Additionally, care instructions in reference to preventing infection are provided in various sections of this ifu.No further information was provided.The manufacturer is closing the file on this event.
|
|
Manufacturer Narrative
|
Manufacturer's investigation conclusion: a specific cause for the reported events (stroke, sepsis, infection) and subsequent patient outcome as well as a direct correlation to heartmate 3 left ventricular assist system (lvas), serial number (b)(4), could not be conclusively determined through this evaluation.The device was not explanted, and product was not returned for evaluation.The relevant sections of the device history records for (b)(4) were reviewed and showed no deviations from manufacturing or quality assurance specification.The heartmate 3 left ventricular assist system (lvas) instructions for use (ifu) rev.C is currently available.¿introduction¿, lists stroke, bleeding, sepsis, infection, and death as adverse events that may be associated with the use of heartmate 3 lvas.¿patient care and management¿, provides information regarding anticoagulation, including recommended international normalized ratio (inr) values.Additionally, care instructions in reference to preventing infection are provided in various sections of this ifu.No further information was provided.The manufacturer is closing the file on this event.
|
|
Event Description
|
It was reported that the patient had multiple comorbid conditions including severe congestive heart failure and cardiogenic shock with history of left ventricular assist device implanted in 2021.The patient presented with lethargy, generalized weakness, headache, cough, and confusion to the emergency room.The patient was having seizure activity, twitching on the left side of the face, left arm was jerking, body was stiff, and had rapid eye movements.A computed tomography was performed and showed a 5 by 3 centimeter right hemorrhagic stroke.The patient had an acute large right parietal hemorrhagic stroke, acute metabolic encephalopathy, warfarin coagulopathy, severe sepsis, possible bilateral pneumonia.Doxycycline, warfarin, and complete comfort measures with no stroke order set, only ordered vitals, dilaudid drip, and other comfort medications.The vad was turned off and the patient passed away.
|
|
Search Alerts/Recalls
|
|